CNO Financial Group Appoints Jess Turner to its Board of Directors
Get Alerts CNO Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.7%
EPS Growth %: +13.8%
Join SI Premium – FREE
CARMEL, Ind.,
"We are very pleased to welcome Jess to CNO's board of directors," said Board Chair
In her role as Executive Vice President and Global Head of Open Banking and API at Mastercard, Turner leads the development and build-out of new products and technologies to enable the future of open banking, while driving innovation with key partners across the ecosystem, including fintech companies and governments globally. Before this leadership position, she served as the Executive Vice President of New Digital Infrastructure and Fintech, where she led the strategy, design, development and commercialization of Mastercard's blockchain, digital assets, crypto and open banking products.
In more than 18 years at Mastercard, she has been responsible for delivering both product and digital solutions and advancing the company's inclusive growth strategy in
Turner received a bachelor's degree in business administration from the University of Miami.
About CNO Financial Group
CNO Financial Group, Inc. (NYSE: CNO) secures the future of middle-income America. CNO provides life and health insurance, annuities, financial services, and workforce benefits solutions through our family of brands, including Bankers Life, Colonial Penn, Optavise and Washington National. Our customers work hard to save for the future, and we help protect their health, income and retirement needs with 3.2 million policies and
View original content to download multimedia:https://www.prnewswire.com/news-releases/cno-financial-group-appoints-jess-turner-to-its-board-of-directors-302264787.html
SOURCE CNO Financial Group
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clear Street Starts MasterCard (MA) at Buy
- Eurofins Agrees to Acquire Element Materials Technology’s Life Sciences Testing Services Business in North America
- Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share